TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
Imaging Technology
NOVEMBER 26, 2023
TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. TeleDaaS’s technology and processes are tightly governed by robust quality methodologies and the platforms are information security compliant.
Let's personalize your content